Last updated: May 04, 2026

Application No. 17/552,413

CARBONIC ANHYDRASE INHIBITORS FOR TREATMENT OF NEISSERIA GONORRHOEAE INFECTION

Final Rejection

Filed

Dec 16, 2021

Priority

Jan 01, 2021 — provisional 63/133,256

Examiner

MCDOWELL, BRIAN E

Art Unit

1624

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Purdue Research Foundation

OA Round

6 (Final)

Interview Optional

— +30.5% interview lift. Examiner has a relatively high allowance rate (74%); +30.5% interview lift. A written response may suffice.

Based on 1106 resolved cases, 2023–2026

Examiner Intelligence

MCDOWELL, BRIAN E View full profile →

Grants 74% — above average

Career Allowance Rate

821 granted / 1106 resolved

+14.2% vs TC avg

Strong +30% interview lift

Without

With

+30.5%

Interview Lift

resolved cases with interview

Typical timeline

2y 2m

Avg Prosecution

56 currently pending

Career history

1162

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

15.0%

-25.0% vs TC avg

§102

19.4%

-20.6% vs TC avg

§112

47.6%

+7.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1106 resolved cases

Prosecution Timeline

Show 8 earlier events

Apr 11, 2025

Response Filed

May 08, 2025

Final Rejection

May 15, 2025

Response after Non-Final Action

Jul 28, 2025

Request for Continued Examination

Jul 30, 2025

Response after Non-Final Action

Aug 21, 2025

Non-Final Rejection

Feb 24, 2026

Response Filed

Mar 09, 2026

Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/575,898

Patent 12612381

CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE

4y 3m to grant Granted Apr 28, 2026

17/801,551

Patent 12606556

TYK-2 INHIBITOR

3y 8m to grant Granted Apr 21, 2026

17/436,225

Patent 12599615

USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES

4y 7m to grant Granted Apr 14, 2026

18/174,983

Patent 12604600

Organic Electroluminescent Element And Novel Iridium Complex

3y 1m to grant Granted Apr 14, 2026

17/054,468

Patent 12559494

NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE

5y 3m to grant Granted Feb 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8

Expected OA Rounds

74%

Grant Probability

99%

With Interview (+30.5%)

2y 2m (~0m remaining)

Median Time to Grant

High

PTA Risk

Based on 1106 resolved cases by this examiner. Grant probability derived from career allowance rate.